// App-Quantinova.ai

WP258 2015 ASA : Alpha-2-antiplasmin Inactivation Reduces Brain Injury, Hemorrhage and Death Following Ischemic Stroke

Researchers

Presenter

  • Aiilyan Houng

Principal Investigators

  • Dong Wang

Medical Centers

  • University of Tennessee, Memphis, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim